Literature DB >> 186345

Measurement and partial characterization of immunoreactive glucagon in gastrointestinal tissues of dogs.

S Morita, K Doi, C C Yip, M Vranic.   

Abstract

We have reported previously that increasing amounts of immunoreactive glucagon (IRG), measured by four specific antisera, appeared in plasma of depancreatized insulin-deficient dogs. It was therefore concluded that pancreatectomy was not accompanied by glucagon deficiency in the dog, but instead excessive amounts of extrapancreatic IRG could contribute to the diabetic syndrome. In order to locate the source of extrapancreatic glucagon, tissue extracts were assayed with anti-glucagon sera 30-K and K-44, which cross-react minimally with crude gut extracts. IRG was detected in all gastrointestinal tissues and in the salivary glands, but not in extracts of liver, kidney, brain, heart atrium, and adenohypophysis. Immunologic dilution curves of extracts from all gastrointestinal tissues were parallel to those of the pure pancreatic glucagon standard, and both antisera (30-K and K-44) measured the same concentrations. The highest concentration of gastrointestinal IRG was found in the fundus and corpus of the stomach. Presence of IRG in gastrointestinal tissues of depancreatized dogs indicates that gastrointestinal cells can not only secrete but also store large amounts of IRG. Extracts of mucosa of stomach fundus were further purified by gel filtration on Biogel P-30 columns. The immunoreactivity in the eluate was assayed by 30-K and a strongly crossreacting antibody, K-4023. One pooled fraction corresponding to marker pancreatic glucagon in its elution volume was found to contain the largest amount of IRG and the highest specific immunoreactivity (IRG/protein concentration). This fraction showed also the highest activity in a glucagon-receptor assay system. Disc gel electrophoresis in the presence of urea resolved this fraction into three immunoreactive components, one of which was identical to pancreatic glucagon in its electrophoretic mobility. It appears, therefore, that mucosa of the upper stomach in the dog contains a polypeptide similar to pancreatic glucagon. We conclude that (a) hyperglucagonemia in the dog can result from excessive secretion of IRG not only by the pancreatic alpha cells but also by cells of the gastrointestinal tract; (b) the highest IRG concentration was found in fundus and corpus of the stomach and lower concentrations throughout the gastrointestinal tract; (c) the IRG component in the stomach displayed immunologic and physical properties similar to pancreatic glucagon.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 186345     DOI: 10.2337/diab.25.11.1018

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

1.  Vagal stimulation and its role in eliciting gastrin but not glucagon release from the isolated perfused dog stomach.

Authors:  P J Lefebvre; A S Luyckx; A H Brassinne
Journal:  Gut       Date:  1978-03       Impact factor: 23.059

2.  The effect of splanchnic viscera removal upon canine liver regeneration.

Authors:  T E Starzl; A Francavilla; K A Porter; J Benichou; A F Jones
Journal:  Surg Gynecol Obstet       Date:  1978-08

Review 3.  Glucagon and diabetes: a reappraisal.

Authors:  P J Lefebvre; A S Luyckx
Journal:  Diabetologia       Date:  1979-06       Impact factor: 10.122

4.  Factors controlling gastric-glucagon release.

Authors:  P J Lefèbvre; A S Luyckx
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

5.  Glucagon and glicentin immunoreactive cells in human colon.

Authors:  P C Colony; V Helmstaedter; A J Moody; J C Garaud; W G Forssmann
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

6.  The physicochemical nature and biological function of extrapancreatic immunoreactive glucagon.

Authors:  S Ikei; K Mori; Y Sakamoto; J Ishii; O Watanabe; M Inoue; M Akagi
Journal:  Gastroenterol Jpn       Date:  1980

7.  Studies on persistent circulating immunoreactive glucagon (IRG) and immunoreactive insulin (IRI) found in eviscerated rats with a functional liver.

Authors:  S S Smith; S J Bhathena; D Nompleggi; J C Penhos; L Recant
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

8.  Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.

Authors:  W A Muller; L Girardier; J Seydoux; M Berger; A E Renold; M Vranic
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  A gastrin releasing peptide from the porcine nonantral gastric tissue.

Authors:  T J McDonald; G Nilsson; M Vagne; M Ghatei; S R Bloom; V Mutt
Journal:  Gut       Date:  1978-09       Impact factor: 23.059

Review 10.  Glucagon-like peptide-1, a new hormone of the entero-insular axis.

Authors:  C Orskov
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.